long COVID and post-acute sequelae of SARS-CoV-2 infection
E999155
UNEXPLORED
Long COVID and post-acute sequelae of SARS-CoV-2 infection refer to a range of persistent or new health problems that continue or emerge weeks to months after the initial COVID-19 illness, affecting multiple organ systems and daily functioning.
All labels observed (1)
| Label | Occurrences |
|---|---|
| long COVID and post-acute sequelae of SARS-CoV-2 infection canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T12746139 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: long COVID and post-acute sequelae of SARS-CoV-2 infection Context triple: [Akiko Iwasaki, researchFocus, long COVID and post-acute sequelae of SARS-CoV-2 infection]
-
A.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
B.
The New Normal: A Roadmap to Resilience in the Pandemic Era
"The New Normal: A Roadmap to Resilience in the Pandemic Era" is a health and wellness book by physician and medical correspondent Dr. Jennifer Ashton that offers practical guidance for coping with and adapting to life during and after the COVID-19 pandemic.
-
C.
Management of the COVID-19 pandemic in Northern Ireland
Management of the COVID-19 pandemic in Northern Ireland refers to the policies, public health measures, and governmental response implemented to control the spread and impact of COVID-19 within Northern Ireland.
-
D.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
E.
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: long COVID and post-acute sequelae of SARS-CoV-2 infection Target entity description: Long COVID and post-acute sequelae of SARS-CoV-2 infection refer to a range of persistent or new health problems that continue or emerge weeks to months after the initial COVID-19 illness, affecting multiple organ systems and daily functioning.
-
A.
COVID-19 pandemic
The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
-
B.
The New Normal: A Roadmap to Resilience in the Pandemic Era
"The New Normal: A Roadmap to Resilience in the Pandemic Era" is a health and wellness book by physician and medical correspondent Dr. Jennifer Ashton that offers practical guidance for coping with and adapting to life during and after the COVID-19 pandemic.
-
C.
Management of the COVID-19 pandemic in Northern Ireland
Management of the COVID-19 pandemic in Northern Ireland refers to the policies, public health measures, and governmental response implemented to control the spread and impact of COVID-19 within Northern Ireland.
-
D.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
E.
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.